N/A Completed N=81 Randomized Triple-blind Supportive Care

Pediatric Laser Acupuncture and Renal Biopsy

Postoperative Pain · Anxiety

Source: ClinicalTrials.gov NCT01879826 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2020

Primary outcomePrimary: Patient Pain/Anxiety — -0.5; 0.8 units on a scale — p=0.044

Summary

The purpose of this study is to test if treatment with laser therapy in pediatric patients undergoing renal biopsies will improve patient satisfaction of the overall procedure. In this study, the participant will receive a laser acupuncture treatment targeting either kidney acupoints or targeting "sham" points not associated with the kidney; the participant will not get both. Both treatment sessions are given by a certified medical acupuncturist. The patient will still receive standard pain control protocols with anesthetic medications like lidocaine plus ketamine or fentanyl and versed during the biopsy, along with pain management after the procedure. All medication will be administered without regard for which group the participant has been randomized, as the treatment team will also be blinded. Hypothesis: We will test the hypothesis that treatment with laser acupuncture in patients undergoing renal biopsies will improve patient satisfaction of the overall procedure. Specific Aims: Specific Aim 1: Determine whether the use of laser acupuncture improves patient's overall satisfaction of renal biopsy. Specific Aim 2: Determine whether the use of laser acupuncture decreases the amount of sedative medication given during renal biopsy.

Outcome Measures

Outcome	Result	p-value
PRIMARY Patient Pain/Anxiety	-0.5; 0.8	0.044 sig
SECONDARY Parent Perception of Patient Pain Report	0.3; 2.3	0.04 sig

Eligibility Criteria

Inclusion Criteria

older than 6 years old
admitted for a transplant or native kidney biopsy performed by pediatric nephrology

Exclusion Criteria

Prisoners
Pregnant females
Those who are unable to participate with the visual analog scale

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01879826). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.